ATE359256T1 - Verfahren zur herstellung von (2r)-2- propyloktansäure - Google Patents

Verfahren zur herstellung von (2r)-2- propyloktansäure

Info

Publication number
ATE359256T1
ATE359256T1 AT00904007T AT00904007T ATE359256T1 AT E359256 T1 ATE359256 T1 AT E359256T1 AT 00904007 T AT00904007 T AT 00904007T AT 00904007 T AT00904007 T AT 00904007T AT E359256 T1 ATE359256 T1 AT E359256T1
Authority
AT
Austria
Prior art keywords
acid
propyloctic
producing
propyloctanoic
octanoic acid
Prior art date
Application number
AT00904007T
Other languages
English (en)
Inventor
Norikazu Toda
Kaoru Yamaguchi
Youichi Iguchi
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE359256T1 publication Critical patent/ATE359256T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42Platinum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/18Carbon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
AT00904007T 1999-02-18 2000-02-17 Verfahren zur herstellung von (2r)-2- propyloktansäure ATE359256T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3975899 1999-02-18

Publications (1)

Publication Number Publication Date
ATE359256T1 true ATE359256T1 (de) 2007-05-15

Family

ID=12561862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904007T ATE359256T1 (de) 1999-02-18 2000-02-17 Verfahren zur herstellung von (2r)-2- propyloktansäure

Country Status (19)

Country Link
US (1) US6608221B1 (de)
EP (3) EP1721882A1 (de)
JP (2) JP4752989B2 (de)
KR (1) KR100666423B1 (de)
CN (4) CN100430364C (de)
AT (1) ATE359256T1 (de)
AU (1) AU776927B2 (de)
BR (1) BR0008261A (de)
CA (1) CA2364308C (de)
DE (1) DE60034316T2 (de)
ES (1) ES2283287T3 (de)
HU (1) HUP0200358A3 (de)
MX (1) MXPA01008241A (de)
NO (1) NO20013971L (de)
NZ (1) NZ513569A (de)
RU (1) RU2297406C2 (de)
TW (1) TWI268921B (de)
WO (1) WO2000048982A1 (de)
ZA (1) ZA200106500B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
JP4178405B2 (ja) 2001-07-18 2008-11-12 小野薬品工業株式会社 脳虚血疾患治療剤
JP2005298334A (ja) * 2001-12-19 2005-10-27 Ono Pharmaceut Co Ltd 新規な中間体化合物およびそれを用いる化合物の製造方法
US7928143B2 (en) * 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
AU2004277826B2 (en) * 2003-10-03 2010-05-27 Ono Pharmaceutical Co., Ltd. Drug containing (2R)-2-propyloctanoic acid as the active ingredient
EP1669066A4 (de) * 2003-10-03 2009-04-29 Ono Pharmaceutical Co Infusionspräparat mit (2r)-2-propyloctansäure als wirkstoff
JP4730303B2 (ja) * 2004-04-28 2011-07-20 小野薬品工業株式会社 (2r)−2−プロピルオクタン酸とアミンとからなる結晶
AU2005306741A1 (en) * 2004-11-16 2006-05-26 Merck & Co., Inc. Prodrugs of (2R)-2-propyloctanoic acid for treatment of stroke
WO2006075596A1 (ja) * 2005-01-13 2006-07-20 Kuraray Co., Ltd. 2-アリルカルボン酸化合物の製造方法
EP2266559A1 (de) 2005-03-15 2010-12-29 Ono Pharmaceutical Co., Ltd. Therapeutischer Wirkstoff zur Behandlung von opthalmischen Erkrankungen
US8975298B2 (en) 2005-06-27 2015-03-10 Ono Pharmaceutical Co., Ltd. Therapeutic agent for pain
CA2625341A1 (en) 2005-10-18 2007-04-26 Ono Pharmaceutical Co., Ltd. Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
WO2007072902A1 (ja) 2005-12-22 2007-06-28 Ono Pharmaceutical Co., Ltd. 急性期脳梗塞治療剤
US20090118542A1 (en) * 2006-02-16 2009-05-07 Shigeya Yamazaki Process for Production of Optically Active Carboxlic Acid Compound
EP2015741A4 (de) * 2006-05-04 2009-12-23 Merck & Co Inc Histondeacetylase-hemmer zur behandlung von neurodegeneration
CN102417445B (zh) * 2011-11-05 2013-11-13 中国科学院山西煤炭化学研究所 一种由马来酸合成丁二酸的方法
CN102675166B (zh) * 2012-05-11 2014-03-26 山东齐都药业有限公司 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法
CN102786407B (zh) * 2012-08-15 2014-04-16 湖北大学 一种制备(2r)-2-丙基辛酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2317019A1 (de) 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
JPH0672123B2 (ja) * 1986-08-21 1994-09-14 セントラル硝子株式会社 トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法
JP2868183B2 (ja) * 1988-02-29 1999-03-10 株式式社三和化学研究所 光学活性を有する4−オキソ−1−ベンゾピラン−2−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法
US5202474A (en) * 1989-06-22 1993-04-13 Monsanto Company Asymmetric catalytic hydrogenation of α-arylpropenoic acids
DK0632008T3 (da) 1993-06-01 1998-09-23 Ono Pharmaceutical Co Pentansyrederivater
JP3032447B2 (ja) * 1995-04-24 2000-04-17 小野薬品工業株式会社 光学活性な2−プロピルオクタン酸の製造方法
JP3084345B2 (ja) * 1995-04-26 2000-09-04 小野薬品工業株式会社 光学活性な2−プロピルオクタン酸の製造方法
TW509672B (en) 1998-05-12 2002-11-11 Ono Pharmaceutical Co Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
JP4730303B2 (ja) * 2004-04-28 2011-07-20 小野薬品工業株式会社 (2r)−2−プロピルオクタン酸とアミンとからなる結晶

Also Published As

Publication number Publication date
CN1636957A (zh) 2005-07-13
HUP0200358A3 (en) 2003-03-28
US6608221B1 (en) 2003-08-19
EP1153910A1 (de) 2001-11-14
HUP0200358A2 (hu) 2002-05-29
MXPA01008241A (es) 2002-08-30
KR100666423B1 (ko) 2007-01-11
DE60034316T2 (de) 2008-01-03
CA2364308C (en) 2010-02-02
ZA200106500B (en) 2003-02-07
NO20013971D0 (no) 2001-08-15
AU776927B2 (en) 2004-09-23
JP4752989B2 (ja) 2011-08-17
EP1153910A4 (de) 2002-08-07
NO20013971L (no) 2001-08-15
KR20010102161A (ko) 2001-11-15
CA2364308A1 (en) 2000-08-24
ES2283287T3 (es) 2007-11-01
CN1907938A (zh) 2007-02-07
BR0008261A (pt) 2002-01-15
CN1341091A (zh) 2002-03-20
AU2573000A (en) 2000-09-04
EP1153910B1 (de) 2007-04-11
TWI268921B (en) 2006-12-21
WO2000048982A1 (en) 2000-08-24
DE60034316D1 (de) 2007-05-24
RU2001125501A (ru) 2004-02-20
EP1714956A1 (de) 2006-10-25
EP1721882A1 (de) 2006-11-15
JP5343925B2 (ja) 2013-11-13
CN1183082C (zh) 2005-01-05
RU2297406C2 (ru) 2007-04-20
CN101100422A (zh) 2008-01-09
CN100430364C (zh) 2008-11-05
NZ513569A (en) 2003-01-31
JP2010248198A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
ATE359256T1 (de) Verfahren zur herstellung von (2r)-2- propyloktansäure
DE69123880D1 (de) Verfahren zur Herstellung von Eicosapentaensäure oder von einem Esterderivat davon
ATE195973T1 (de) Enzymatische verfahren zur resolution von enantiomeren-mischungen nützlich wie zwischenprodukte zur herstellung von taxanen
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
DE68913714D1 (de) Verfahren zur Herstellung von ungesättigter Carbonsäure oder ihrem Ester.
DE3780145D1 (de) Verfahren zur herstellung hochkonzentrierter phosphorsaeure.
ATE235475T1 (de) Intermediate und verfahren zur herstellung optisch aktiver oktansäure-derivate
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DE3866766D1 (de) Verfahren zur herstellung von methacrylsaeureestern.
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ATA342186A (de) Verfahren zur herstellung eines organischen carbonsaeureanhydrids
ATE111898T1 (de) Verfahren zur herstellung von chinoloncarbonsäuren.
ATE194342T1 (de) Verfahren zur herstellung von optisch aktivem 3- chinuclidinol
ATE205498T1 (de) Verfahren zur herstellung von kaliumclavulanat
DE59007810D1 (de) Verfahren zur enzymatischen Spaltung von 2-Arylpropionsäurevinylestern.
DE69111857D1 (de) Verfahren zur Herstellung von organischen Carbonsäureestern.
DE68928516D1 (de) Verfahren zur Herstellung von optisch aktiven Glycidat-Estern
DE3688302D1 (de) Verfahren zur herstellung von 7-aca-derivaten.
DE69310427D1 (de) Verfahren zur Herstellung von Carbonsäuren durch Reaktion der Alkane mit Kohlenmonoxyd
DE58905010D1 (de) Verfahren zur herstellung von 5-chlor-3-chlorsulfonyl-2-thiophencarbonsaeureestern.
ATE125700T1 (de) Ibuprofen- und s-(+)-ibuprofen zubereitungen und verfahren zu ihrer herstellung.
ATE138414T1 (de) Verfahren zur herstellung von optisch aktiver 2- arylpropionsäure
DE59000677D1 (de) Verfahren zur herstellung von 2-cyan-3,3-diarylacrylsaeureestern.
JPS6422837A (en) Racemization of optically active chrysanthemum-monocarboxylic acids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties